349 related articles for article (PubMed ID: 36374661)
1. Amorphous NiB@IrO
Wang Q; Shaik F; Lu X; Zhang W; Wu Y; Qian H; Zhang W
Acta Biomater; 2023 Jan; 155():575-587. PubMed ID: 36374661
[TBL] [Abstract][Full Text] [Related]
2. High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X; Li D; Chen L; He H; Wang Q; Hong C; He J; Gao X; Yang Y; Jiang B; Nie G; Yan X; Gao L; Fan K
ACS Nano; 2021 Mar; 15(3):5735-5751. PubMed ID: 33705663
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
Lv W; Cao M; Liu J; Hei Y; Bai J
Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
[TBL] [Abstract][Full Text] [Related]
4. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
5. Interfacial strong interaction-enabling cascade nanozymes for apoptosis-ferroptosis synergistic therapy.
Wei L; Wang Z; Lu X; Chen J; Zhai Y; Huang Q; Pei S; Liu Y; Zhang W
J Colloid Interface Sci; 2024 Jan; 653(Pt A):20-29. PubMed ID: 37708728
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
7. GSH-depleting and H
Li J; Yi W; Luo Y; Yang K; He L; Xu C; Deng L; He D
Acta Biomater; 2023 Jan; 155():588-600. PubMed ID: 36328125
[TBL] [Abstract][Full Text] [Related]
8. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
9. Defect engineering to tailor structure-activity relationship in biodegradable nanozymes for tumor therapy by dual-channel death strategies.
Su Y; Lv M; Huang Z; An N; Chen Y; Wang H; Li Z; Wu S; Ye F; Shen J; Li A
J Control Release; 2024 Mar; 367():557-571. PubMed ID: 38301929
[TBL] [Abstract][Full Text] [Related]
10. Hemin-incorporating DNA nanozyme enabling catalytic oxygenation and GSH depletion for enhanced photodynamic therapy and synergistic tumor ferroptosis.
Xiao X; Chen M; Zhang Y; Li L; Peng Y; Li J; Zhou W
J Nanobiotechnology; 2022 Sep; 20(1):410. PubMed ID: 36109814
[TBL] [Abstract][Full Text] [Related]
11. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
12. A Molybdenum Disulfide Nanozyme with Charge-Enhanced Activity for Ultrasound-Mediated Cascade-Catalytic Tumor Ferroptosis.
Wang L; Zhang X; You Z; Yang Z; Guo M; Guo J; Liu H; Zhang X; Wang Z; Wang A; Lv Y; Zhang J; Yu X; Liu J; Chen C
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217448. PubMed ID: 36585377
[TBL] [Abstract][Full Text] [Related]
13. NaYF
Chen Y; Li H; Hou B; Wu A; Wu W; Li C; Wang H; Chen D; Wang X
Small; 2024 Jan; 20(1):e2304438. PubMed ID: 37661593
[TBL] [Abstract][Full Text] [Related]
14. Ultrasmall Self-Cascade AuNP@FeS Nanozyme for H
Zhan J; Liu J; Yang J; Huang L; Lu Y; Lu X; Zhu J; Yang S; Shen Z
ACS Appl Mater Interfaces; 2023 Oct; 15(39):46213-46225. PubMed ID: 37740721
[TBL] [Abstract][Full Text] [Related]
15. Dual enzyme-like Co-FeSe
Zhang J; Ha E; Li D; He S; Wang L; Kuang S; Hu J
J Mater Chem B; 2023 May; 11(19):4274-4286. PubMed ID: 37140154
[TBL] [Abstract][Full Text] [Related]
16. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular Nanozyme System Based on Polydopamine and Polyoxometalate for Photothermal-Enhanced Multienzyme Cascade Catalytic Tumor Therapy.
Zhang Z; Ding D; Liu J; Huang C; Li W; Lu K; Cheng N
ACS Appl Mater Interfaces; 2023 Aug; 15(32):38214-38229. PubMed ID: 37535452
[TBL] [Abstract][Full Text] [Related]
18. Vanadium Oxide Nanozymes with Multiple Enzyme-Mimic Activities for Tumor Catalytic Therapy.
Zeng X; Wang H; Ma Y; Xu X; Lu X; Hu Y; Xie J; Wang X; Wang Y; Guo X; Zhao L; Li J
ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36897191
[TBL] [Abstract][Full Text] [Related]
19. NADPH Oxidase-Like Nanozyme for High-Efficiency Tumor Therapy Through Increasing Glutathione Consumption and Blocking Glutathione Regeneration.
Han D; Ding B; Zheng P; Yuan M; Bian Y; Chen H; Wang M; Chang M; Kheraif AAA; Ma P; Lin J
Adv Healthc Mater; 2024 Apr; 13(11):e2303309. PubMed ID: 38214472
[TBL] [Abstract][Full Text] [Related]
20. Bimetallic PtPd Atomic Clusters as Apoptosis/Ferroptosis Inducers for Antineoplastic Therapy through Heterogeneous Catalytic Processes.
Wang X; He M; Zhao Y; He J; Huang J; Zhang L; Xu Z; Kang Y; Xue P
ACS Nano; 2024 Mar; 18(11):8083-8098. PubMed ID: 38456744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
